Tryptophan-like side chain holding aptamers inhibit respiratory syncytial virus infection of lung epithelial cells

Sci Rep. 2023 Jun 9;13(1):9403. doi: 10.1038/s41598-023-36428-2.

Abstract

Respiratory syncytial virus (RSV) is a leading cause of serious and even fatal acute lower respiratory tract infections in infants and in the elderly. Potent RSV neutralization has been achieved by antibodies that selectively bind the prefusion form of the viral fusion (F) protein. We hypothesised that similar potent neutralization could be achieved using F protein targeting aptamers. Aptamers have yet to reach their translational potential for therapeutics or diagnostics due to their short half-life and limited range of target-aptamer interactions; these shortcomings can, however, be ameliorated by application of amino acid-like side chain holding nucleotides. In this study, a stabilized version of the prefusion RSV F protein was targeted by aptamer selection using an oligonucleotide library holding a tryptophan-like side chain. This process resulted in aptamers that bound the F protein with high affinity and differentiated between its pre- and postfusion conformation. Identified aptamers inhibited viral infection of lung epithelial cells. Moreover, introduction of modified nucleotides extended aptamer half-lives. Our results suggest that targeting aptamers to the surface of viruses could yield effective drug candidates, which could keep pace with the continuously evolving pathogens.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Epithelial Cells
  • Humans
  • Lung
  • Oligonucleotides
  • Respiratory Syncytial Virus Infections* / drug therapy
  • Respiratory Syncytial Virus, Human*
  • Tryptophan
  • Viral Fusion Proteins

Substances

  • Tryptophan
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Oligonucleotides
  • Viral Fusion Proteins